首页> 美国卫生研究院文献>Clinical and Molecular Hepatology >The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

【2h】

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

机译：聚乙二醇干扰素联合利巴韦林对慢性丙型肝炎患者脂质代谢和胰岛素抵抗的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimsLipid profile and insulin resistance (IR) are associated with hepatitis C virus (HCV) and may predict the chronic hepatitis C (CHC) treatment response. The aim of this study was to determine the association between CHC treatment response and lipid profile and IR change during treatment.

机译：背景/目的脂质概况和胰岛素抵抗（IR）与丙型肝炎病毒（HCV）相关，并可能预测慢性丙型肝炎（CHC）治疗反应。这项研究的目的是确定CHC治疗反应与治疗期间血脂和IR变化之间的关系。

著录项

期刊名称 Clinical and Molecular Hepatology
作者
Hee Jae Jung; Young Seok Kim; Sang Gyune Kim; Yun Nah Lee; Soung Won Jeong; Jae Young Jang; Sae Hwan Lee; Hong Soo Kim; Boo Sung Kim;
展开▼
作者单位

展开▼
年(卷),期 2014(20),1
年度 2014
页码 38–46
总页数 9
原文格式 PDF
正文语种
中图分类分子生物学;
关键词
Lipid metabolism Insulin resistance Chronic hepatitis C;

机译：脂质代谢;胰岛素抵抗;慢性丙型肝炎;

相似文献

外文文献
中文文献
专利

1. Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment [J] . Yang Hyun Baek Sung Wook Lee Hyun Seung Yoo Hyun Ah Yoon Ja Won Kim Young Hoon Kim Ha Youn Kim, Sang Young Han Gut and Liver . 2007,第1期

机译：胸腺素α-1与聚乙二醇干扰素和利巴韦林合用在先前未接受聚乙二醇干扰素和利巴韦林治疗的慢性丙型肝炎患者中
2. Lead-in treatment with interferon-??/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype [J] . ItokawaN., AtsukawaM., TsubotaA., Journal of gastroenterology and hepatology . 2013,第3期

机译：干扰素-β/利巴韦林的导入治疗可能会改变聚乙二醇化干扰素α-2b/利巴韦林联合治疗IL28B小基因型慢性丙型肝炎患者的早期丙型肝炎病毒动力学
3. Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial [J] . Iwane Shinji, Mizuta Toshihiko, Kawaguchi Yasunori, Internal medicine. . 2015,第24期

机译：饮食和运动减轻体重对聚乙二醇干扰素加利巴韦林对慢性丙型肝炎胰岛素抵抗患者抗病毒作用的影响：一项随机对照试验
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment [O] . Yang Hyun Baek, Sung Wook Lee, Hyun Seung Yoo, 2007

机译：胸腺素α-1与聚乙二醇干扰素和利巴韦林合用在先前未接受聚乙二醇干扰素和利巴韦林治疗的慢性丙型肝炎患者中
7. The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients [O] . Hee Jae Jung, Young Seok Kim, Sang Gyune Kim, 2014

机译：聚乙二醇化干扰素和利巴韦林联合治疗对慢性丙型肝炎患者脂代谢及胰岛素抵抗的影响

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients

摘要

著录项

相似文献

相关主题

期刊订阅